Antithrombin

Related by string. antithrombin * * plasma derived antithrombin . hereditary antithrombin deficient . human antithrombin protein . hereditary antithrombin deficiency . antithrombin protein . antithrombin III . human antithrombin . antithrombin deficiency . recombinant antithrombin . extra antithrombin protein . recombinant antithrombin product *

Related by context. Frequent words. (Click for all words.) 76 Recombinant Human 73 Meets Primary Endpoint 72 Pulmonary Arterial Hypertension 71 Drug Candidate 71 Epidermal Growth Factor Receptor 71 Improves Survival 70 Immune Globulin Intravenous 70 Diabetic Neuropathy 70 Receives Orphan Drug Designation 70 Thrombin 70 Initiates Phase II 69 Single Dose 69 Inhibits 69 Epithelial 69 Phase III Clinical Trial 69 Drug Shows Promise 69 Angiotensin II 68 Ischemic 68 Significantly Improves 68 FDA Clears 68 Inactivation 68 Mucosal 67 Epratuzumab 67 Lubiprostone 67 Well Tolerated 67 Aliskiren 67 Monoclonal Antibody 67 Autologous 67 Inflammatory Diseases 67 Small Molecule 67 Tumor Growth 67 Placental 67 Androgen 67 Completes Enrollment 67 Initiate Phase 67 peptide hormone 67 Preclinical Data 67 Gastric Cancer 67 coagulation factors 67 Endothelin 67 Announces FDA Clearance 67 von Willebrand factor 67 Metastatic Melanoma 67 Low Dose 67 Insulin Resistance 67 vWF 66 Phase III Trial 66 Erythropoietin 66 Factor VIIa 66 Eculizumab 66 Embolization 66 Antifungal 66 Immunoglobulin 66 Protease 66 Polymorphisms 66 Phosphorylation 66 Bioavailability 66 Clinical Trial Results 66 Golimumab 66 Acute Ischemic Stroke 66 Tacrolimus 66 Radiofrequency Ablation 65 FDA Accepts 65 Am J Clin 65 Anti Inflammatory 65 J Am Coll 65 Atopic Dermatitis 65 Dasatinib 65 Renin 65 Presents Positive 65 cell adhesion molecule 65 MKC# 65 Intracellular 65 PRIALT 65 Estradiol 65 Renal Cell Carcinoma 65 Pivotal Phase III 65 Lenalidomide 65 Hepatocellular Carcinoma 65 J Am Acad 65 Gene Mutation 65 Reduces Risk 65 Influenza Virus 65 Commences Phase 65 Glucagon 65 Cethromycin 64 GAMMAGARD LIQUID 64 Patient Enrollment 64 amikacin 64 Pivotal Trial 64 CGRP 64 Drug Resistant 64 Vascular Endothelial Growth 64 Hepatic 64 Metastatic Colorectal Cancer 64 Elderly Patients 64 liposomal formulation 64 Cyclophosphamide 64 Pivotal Phase 64 Fatty Acid 64 Overactive Bladder

Back to home page